PL212183A1 - - Google Patents

Info

Publication number
PL212183A1
PL212183A1 PL21218378A PL21218378A PL212183A1 PL 212183 A1 PL212183 A1 PL 212183A1 PL 21218378 A PL21218378 A PL 21218378A PL 21218378 A PL21218378 A PL 21218378A PL 212183 A1 PL212183 A1 PL 212183A1
Authority
PL
Poland
Application number
PL21218378A
Other versions
PL117869B1 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PL212183A1 publication Critical patent/PL212183A1/xx
Publication of PL117869B1 publication Critical patent/PL117869B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • C07D257/06Five-membered rings with nitrogen atoms directly attached to the ring carbon atom
PL1978212183A 1978-01-16 1978-12-27 Process for preparing novel analogs of prostaglandins PL117869B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86956978A 1978-01-16 1978-01-16
US89373178A 1978-04-05 1978-04-05

Publications (2)

Publication Number Publication Date
PL212183A1 true PL212183A1 (da) 1980-02-11
PL117869B1 PL117869B1 (en) 1981-08-31

Family

ID=27128123

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1978212183A PL117869B1 (en) 1978-01-16 1978-12-27 Process for preparing novel analogs of prostaglandins

Country Status (28)

Country Link
JP (1) JPS54100378A (da)
AR (1) AR222817A1 (da)
AT (1) AT367755B (da)
AU (1) AU507853B2 (da)
CA (1) CA1152502A (da)
CH (1) CH635833A5 (da)
DD (1) DD141155A5 (da)
DE (1) DE2901476C3 (da)
DK (1) DK523378A (da)
ES (1) ES482421A1 (da)
FI (1) FI790120A (da)
FR (1) FR2414503A1 (da)
GB (1) GB2012272B (da)
GR (1) GR72747B (da)
IE (1) IE48175B1 (da)
IL (1) IL56433A (da)
IN (1) IN150279B (da)
IT (1) IT1110992B (da)
LU (1) LU80789A1 (da)
NL (1) NL7900292A (da)
NO (1) NO790122L (da)
NZ (1) NZ189377A (da)
PH (3) PH15031A (da)
PL (1) PL117869B1 (da)
PT (1) PT69076A (da)
SE (1) SE427657B (da)
SU (1) SU831071A3 (da)
YU (1) YU4579A (da)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE788209A (fr) * 1971-09-01 1973-02-28 Pfizer Derives tetrazoyliques des prostaglandines naturelles
DD118856A5 (da) * 1972-11-08 1976-03-20
IE43462B1 (en) * 1975-06-23 1981-03-11 Pfizer Substituted tetranorprostaglandins
DE2559093C3 (de) * 1975-12-30 1981-12-24 Pfizer Inc., 10017 New York, N.Y. 2-Desarboxy-2-[tetrazol-5-yl]-11-desoxy-ω-pentanorprostaglandine der E- oder F-Reihe und deren C↓15↓-Epimere
US4404372A (en) * 1977-06-13 1983-09-13 Pfizer Inc. 15-Substituted-ω-pentanorprostaglandin derivatives

Also Published As

Publication number Publication date
PT69076A (en) 1979-02-01
IE790060L (en) 1979-07-16
PH15031A (en) 1982-05-13
GR72747B (da) 1983-12-02
GB2012272B (en) 1982-10-20
IT7919290A0 (it) 1979-01-15
DE2901476B2 (de) 1981-06-04
LU80789A1 (fr) 1980-08-08
FR2414503A1 (fr) 1979-08-10
CA1152502A (en) 1983-08-23
GB2012272A (en) 1979-07-25
NZ189377A (en) 1981-05-15
DD141155A5 (de) 1980-04-16
AU507853B2 (en) 1980-02-28
DE2901476C3 (de) 1982-04-22
AU4335979A (en) 1979-07-26
IT1110992B (it) 1986-01-13
FR2414503B1 (da) 1981-12-24
SE7900353L (sv) 1979-07-17
IL56433A (en) 1982-04-30
IN150279B (da) 1982-09-04
FI790120A (fi) 1979-07-17
PH15643A (en) 1983-03-11
AR222817A1 (es) 1981-06-30
ATA27579A (de) 1981-12-15
NL7900292A (nl) 1979-07-18
PL117869B1 (en) 1981-08-31
IL56433A0 (en) 1979-03-12
DE2901476A1 (de) 1979-07-19
IE48175B1 (en) 1984-10-17
PH15653A (en) 1983-03-11
AT367755B (de) 1982-07-26
CH635833A5 (fr) 1983-04-29
JPS54100378A (en) 1979-08-08
YU4579A (en) 1983-01-21
ES482421A1 (es) 1980-04-01
DK523378A (da) 1979-07-17
NO790122L (no) 1979-07-17
SE427657B (sv) 1983-04-25
SU831071A3 (ru) 1981-05-15

Similar Documents

Publication Publication Date Title
FR2413992B1 (da)
AU3898778A (da)
AU3803078A (da)
FR2414503B1 (da)
FR2413960B1 (da)
AU73950S (da)
AU3892778A (da)
BG25897A1 (da)
BG25922A1 (da)
BG25806A1 (da)
BE871570A (da)
BG25816A1 (da)
BG25818A1 (da)
BG25835A1 (da)
BG25836A1 (da)
BG25858A1 (da)
BG25871A1 (da)
BG25872A1 (da)
BG25874A1 (da)
BG25875A1 (da)
BG25879A1 (da)
BG25889A1 (da)
BG25954A1 (da)
BG25898A1 (da)
BG25902A1 (da)